CML-431 Second Line Treatment with Tyrosine Kinase Inhibitors (TKI) in Chronic Myeloid Leukemia (CML) in Colombia. Report of the RENEHOC-ACHO Investigators
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2023)
Key words
chronic myeloid leukemia,second line,Colombia,registry
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined